Global NGS-based RNA-seq Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Factors such as the advantages of RNA-seq over microarray technology, technological advancements in RNA-seq products, increasing number of RNA-seq grants, increasing number of research activities, and rapid growth in precision medicine are driving the growth of the NGS-based RNA-seq market. Scope of the Report: This report focuses on the NGS-based RNA-seq in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The hospitals and clinics segment is expected to register the highest growth due to the growing number of agreements between companies and hospitals for the development of advanced tests and products catering to the specific needs of hospitals and clinics. The worldwide market for NGS-based RNA-seq is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study. Market Segment by Manufacturers, this report covers Illumina Thermo Fisher Scientific Pacific Biosciences Of California Qaigen F. Hoffmann-La Roche Agilent Technologies Oxford Nanopore Technologies Perkinelmer Eurofins Scientific Gatc Biotech Macrogen Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argent ...
Table of Contents 1 Market Overview 1.1 NGS-based RNA-seq Introduction 1.2 Market Analysis by Type 1.2.1 SBS 1.2.2 SMRT 1.3 Market Analysis by Applications 1.3.1 Transcriptome Epigenetics 1.3.2 Small RNA 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2013-2023) 1.4.1.2 Canada Market States and Outlook (2013-2023) 1.4.1.3 Mexico Market States and Outlook (2013-2023) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2013-2023) 1.4.2.2 France Market States and Outlook (2013-2023) 1.4.2.3 UK Market States and Outlook (2013-2023) 1.4.2.4 Russia Market States and Outlook (2013-2023) 1.4.2.5 Italy Market States and Outlook (2013-2023) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast ...
5459

8572

OUR CLIENT